Ferriprox for sickle cell anemia
FERRIPROX® (deferiprone) is an iron chelator indicated for the treatment of patients with iron overload form transfusions due to thalassemia syndromes when current chelation therapy, most commonly Exjade, is inadequate. The approval in second line is reasonable both because the studies for approval were done in second line and because Ferroprox may be inferior to Exjade in first line (Cemak et al). This is not an innocuous drug; the most serious
Read more